Proequities, Inc.
- SEC CIK
- 0000752798
- Latest filing
- Aug 12, 2025
SAGE holding history
Sage Therapeutics, Inc. in every 13F filed by Proequities, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SAGE overviewAll 13F holders of SAGEFull Q2 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −1,000−100.0% | Sold out | Holders |
| Q3 2024 | 1,000 | $7.22K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,000 | $10.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,000 | $18.7K | <0.1% | −1−0.1% | Reduced | Holders |
| Q4 2023 | 1,001 | $21.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,001 | $20.6K | <0.1% | +1,001 | New | Holders |